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Abstract 
Conventional disciplinary research approach is losing momentum in the face of dynamic health challenges of the 21st 
century. There is a need for a new, suitable approach, to tackle these emerging and re-emerging human and animal 
diseases through integrating livestock and human health research in a cross-disciplinary approach for greater impact. 
This is particularly important for the developing world owing to the closer contact of humans with animals as well as 
the consumption of raw animal products, worsened by low levels of literacy. Animals are the major source of today’s 
emerging and re-emerging infectious diseases that threaten both human and animal populations of the world. Among 
recent examples are SARS (severe acute respiratory syndrome), the Hendra and Nipah virus infections, BSE or mad cow 
disease (bovine spongiform encephalopathy) and now highly pathogenic avian influenza (HPAI), or bird flu. In addition, 
bovine tuberculosis and rift valley fever (RVF) are some examples of important re-emerging zoonoses. In recent years, 
bovine tuberculosis has become increasingly important with the HIV and AIDS pandemic in the developing world. This 
paper highlights the past and current research portfolio of ILRI and its partners, focusing on diseases that are 




Veterinary public health (VPH) is not integrated into the 
mainstream of public health services in sub-Saharan 
African countries. There are no formal mechanisms within 
government public health services through which 
veterinary skills and resources can be effectively 
harnessed to bear upon community health. There is no 
conscious, overt or substantial effort by public authorities 
to incorporate VPH services in the overall approach to 
public health. VPH activities cover mainly the control of 
the major animal diseases transmissible to man 
(zoonoses), meat inspection and, to a limited degree, the 
quality control of milk, fish and their products. These 
services are carried out by the Veterinary Services of the 
Ministry of Agriculture in each country (1). 
 
Zoonotic diseases, transmitted between humans and 
animals, are mostly associated with people who have close 
direct contact with animals or indirect contact via vector 
or other transmission vehicles. Farmers, pastoralists, 
veterinarians, butchers and abattoir workers are people 
with a high risk of zoonotic infections. Zoonoses have 
important impacts on public health and the economies of 
the people who depend on animal agriculture. Taylor et al. 
(2) reported the number of zoonotic infections at 868 
representing 61% of all infectious organisms identified to 
be pathogenic to humans. Some of these infections have 
been recognised early in history (e.g. rabies) while others 
have recently emerged (e.g. SARS, BSE, HPAI). For 
example, raw milk consumption was recognised and 
proved as means of transmission for bovine TB only two 
decades ago, and pasteurisation drastically reduced the 
disease occurrence in Europe.  
 
Measures taken to control major diseases in Europe 
include disease surveys, monitoring, and control through 
concerted efforts of important key players in the food 
chain (e.g. slaughterhouses and milk processors); these 
have reduced the prevalence of many zoonotic diseases. In 
contrast, many zoonotic infections are still common in the 
sub-Saharan African countries. The occurrence of 
zoonotic diseases such as bovine TB, rabies, RVF, HPAI, 
brucellosis, and anthrax in humans could be reduced or 
eliminated if the diseases are controlled in livestock. 
Hence, vaccinating livestock or companion animals 
against these diseases should also be considered as part of 
public health measures.  
 
Despite the above challenges that could have acted as a 
focal point for change, there has not been a cross-
disciplinary breakthrough in collaboration among relevant 
professionals and other key stakeholders in targeting 
zoonoses. This paper summarises research focus areas at 
ILRI, areas of collaboration, and a way forward for 
zoonoses in the context of developing countries. 
 
Concept of cross-disciplinary approach – a need for 
change 
Despite huge international and national efforts towards 
improving health and livelihoods of people, there has not 
been substantial progress towards achieving the 
Millennium Development Goals (MDGs) set for health. In 
spite of the increasing challenge from emerging and re-
emerging zoonotic infections in the world, collaboration 
among professionals has not achieved momentum. There 
is a need for a strategic shift in the types of collaborations 
– from mono-disciplinary to cross-disciplinary and 
participatory approaches. 
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Problems are usually multidimensional and interlinked 
and the search for solutions calls for application of the 
combined methodologies as well as mobilisation of new 
ideas of expertise and application of theoretical 
frameworks which transcend traditional professional 
boundaries (3). Cross-disciplinarity is a cover term for 
different types of collaboration. By definition a discipline 
is a complex phenomenon with social as well as cognitive 
aspects, “a community, a network of communication, a 
particular set of values and beliefs, a domain, a mode of 
enquiry, and a conceptual structure” (4). Rosenfield (1932, 
1951) cited in Aargaard-Hansen et al. (3) distinguished 
three different levels of cross-disciplinary collaboration:  
A.  Multidisciplinary – researchers work in parallel or  
      sequentially from disciplinary-specific base to  
      address common problem 
B.  Interdisciplinary – researchers work jointly but still  
      from disciplinary-specific base to address common  
      problem 
C.  Trans-disciplinary – researchers work jointly using  
      shared conceptual framework drawing together  
      disciplinary-specific theories, concepts, and  
      approaches to address common problem. Cross- 
      disciplinary approach can provide more useful  
      answers to the pertinent problem because it applies  
      more holistic view. Moreover, collaboration between  
      different disciplines increases the possibility of  
      raising new and innovative research questions and  
      provision of cross-fertilisation in terms of  
     methodologies and theories and direct academic  
      benefit per se. 
 
Therefore, it is time for change in addressing zoonoses 
research to generate viable control options through cross-
disciplinary collaboration for all professionals and 
stakeholders. 
 
Zoonoses research by the ILRI 
ILRI conducts research to protect and enhance the 
physical human capital of the poor by developing 
strategies to reduce health risks and improve nutritional 
benefits associated with livestock keeping. Other projects 
focused on the use of water and feed for livestock also 
consider human health impacts. ILRI is working to 
improve understanding of the links between livestock 
keeping and the health and nutrition of poor people, 
particularly those engaging in smallholder livestock 
production and marketing. Activities underway include 
field studies, literature reviews and explorations of the 
ways in which livestock keeping might benefit the care of 
people with HIV/AIDS. 
 
Poor people in developing countries have a high risk of 
exposure to zoonoses. ILRI is helping to bridge the 
artificial divide between animal and human health, and 
helping to bring out more clearly the links between 
agriculture and health. With over three-quarters of human 
infections having a zoonotic origin, the need to examine 
the epidemiological relationships between pathogens and 
their animal and human hosts is paramount. Poor 
households that keep livestock often live in close 
proximity to their animals, with animals and people alike 
living in poor sanitary conditions (5). The several species 
of livestock kept by the poor benefit from little if any 
veterinary care, and medical facilities for the people 
themselves are also scarce. Poor keepers and non-keepers 
of livestock alike typically consume livestock products 
that have not been subject to inspection or improved 
processing and storage. Furthermore, many developing 
countries lack the information, awareness and control 
strategies needed to control zoonotic diseases, often 
because conventional disease control and food safety 
strategies are ill-suited or too expensive for smallholder 
production and marketing systems. Typically, little 
investment has been made to develop appropriate control 
strategies and there is a lack of coordination between the 
relevant veterinary and medical sectors. Through a joint 
research programme with the Swiss Tropical Institute, 
ILRI research is addressing the strategic methodological 
challenge of integrating veterinary-medical assessments 
of the impacts of the zoonotic disease burden on 
livelihoods of the poor. 
 
I. Bovine tuberculosis 
Due to the global importance of tuberculosis as one of the 
most prevalent infectious diseases and leading cause of 
death and because the infection caused by bovine tubercle 
bacillus, Mycobacterium bovis, is clinically 
indistinguishable from tuberculosis caused by 
Mycobacterium tuberculosis, ILRI has recognized the 
disease as one of the most important zoonosis for 
collaborative research. In this connection ILRI has been 
undertaking research in bovine TB both directly and 
indirectly in collaboration with partners, examples are 
highlighted below: 
 
1. The role of ILRI in contributing to novel vaccination 
strategies for control of bovine tuberculosis in cattle 
and understanding the immunological basis of breed 
differences in susceptibility to the disease: 
 
The first context in which ILRI became involved in bovine 
tuberculosis research was in evaluation of heterologous 
prime-boost vaccination regimes based on  priming with 
plasmid DNA or avian poxvirus antigen constructs and 
boosting with the same recombinant antigen expressed in 
replication attenuated poxviruses in cattle.  Such strategies 
had previously been demonstrated to induce immunity, 
based on CD4 and CD8 T cells, against several diseases in 
both rodents and primates. The ILRI study demonstrated 
that conceptually similar prime-boost vaccination 
strategies using the p85a antigen of M. tuberculosis, which 
is conserved with the M. bovis homologue, were highly 
effective in inducing antigen-specific gamma interferon 
secreting CD4 and CD8 T cells, detected using a bovine 
ELISPOT assay, in Bos indicus cattle (6). T cell responses 
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induced by priming with either plasmid DNA or fowlpox 
p85a recombinant antigen expression constructs were 
enhanced by boosting with modified vaccinia virus 
Ankara (MVA) administered intradermally. Intradermal 
priming was markedly more effective than intramuscular 
delivery of the priming dose for MVA boosting in cattle. 
Fowlpox or plasmid DNA priming were both effective and 
using either fowlpox or DNA priming there was a 
significant bias toward induction of CD4, rather than CD8 
T cell responses. These data illustrated the general 
applicability of prime-boost vaccination strategies for 
induction of antigen-specific T-cell responses and 
suggested that the method may be useful for development 
of veterinary vaccines. Due to the lack of a BSL3 
containment facility at ILRI it was not possible to perform 
challenge experiments with virulent M. bovis to test 
whether the T cell responses induced might be protective. 
 
A growing body of evidence suggests that Zebu cattle (Bos 
indicus) are more resistant to Mycobacterium bovis 
infection than exotic (Bos taurus) cattle. As long ago as 
1940, Carmichael concluded that the incidence of bovine 
TB in Uganda, was dramatically lower in Zebu (Bos 
indicus) cattle 0.1–0.7%, compared to Ankole (Bos 
taurus) 12.5–41.4% (7). More recently, a comparison of 
slaughterhouse examinations in India indicated that Bos 
indicus breeds were less affected by bovine TB than pure 
European breeds like Jersey, Holstein-Friesians and 
Brown-Swiss (8). Skin testing results compiled in Ethiopia 
further support the hypothesis that cattle breeds differ in 
their relative susceptibility to bovine TB. Tadelle (9) 
found that in central Ethiopia local Bos indicus breeds had 
much lower prevalence rates (5.6%) than exotic breeds 
(mainly Holsteins, 86.4%); crosses showed 13.9% 
prevalence. Similar differences in prevalence rates and 
severity of pathology have also recently been 
demonstrated between Holsteins and Zebus north-east of 
Addis Ababa, by Ameni and co-workers (10). 
 
In view of this evidence for differential susceptibility of 
breeds to bovine TB derived from field studies, ILRI is 
currently performing a  comparative analysis of the 
immune  responses and pathology of experimentally 
infected cattle of East African Boran (Bos indicus) and 
Friesian (Bos taurus) breeds. This represents one module 
within a Wellcome Trust-funded Animal Health in the 
Developing World project, involving an international 
consortium which seeks to make a systematic survey of 
the prevalence, genotypes and economic impact of bovine 
TB in both livestock and humans, focused on Ethiopia. It 
is envisaged that the results may be synergistic with the 
definition of genomic regions associated with differences 
in bovine TB prevalence identified using single nucleotide 
polymorphisms that differentiate Bos indicus and Bos 
taurus. These data may ultimately provide insights into the 
molecular basis of the resistance/susceptibility phenotype 
in cattle. 
 
2. Comparison between comparative tuberculin and 
gamma-interferon tests for the diagnosis of bovine 
tuberculosis in Ethiopia (11) 
 
Comparative cervical tuberculin (CCT) test as 
standard test for the detection of bovine tuberculosis 
(12) has been in use since the last two decades and 
measuring gamma-interferon release in a whole-
blood culture system has been developed (13) as a 
new diagnostic method for bovine tuberculosis. Diana 
and Carole (14) found that single caudal-fold skin test 
as more sensitive than the commercial IFN-γ test. 
However, the sensitivities and specificities of the 
IFN- γ and CCT tests have not been compared before. 
A study aimed at determining and comparing the 
sensitivities and specificities of the comparative 
cervical tuberculin (CCT) and gamma-interferon 
(IFN-γ) tests for the diagnosis of bovine tuberculosis 
was conducted on 30 Zebu oxen in Ethiopia. The 
results of the tests were compared with the presence 
of acid-fast bacilli found by bacteriological culturing 
and histopathological examinations. The results 
indicated that the sensitivity of CCT was 90.9% and 
its specificity was 100%. Those of the commercial 
IFN-γ test were determined to be 95.5% and 87.7%, 
respectively. No significant differences were found 
between the sensitivities or the specificities of the two 
tests. It was therefore concluded that the choice 
between the two tests depends on their cost and 
simplicity and on livestock management and time 
factors rather than on their respective diagnostic 
value. 
 
3. Kinetics of interferon-γ (IFN-γ) release in the 
peripheral blood of calves vaccinated with BCG 
 
Buddle et al. (15), studying on the efficacy of BCG, 
have shown that a low dose of BCG will protect 
calves from experimental infection with M. bovis. 
One of the mechanisms by which BCG protected 
calves from experimental infection is by inducing the 
release of IFN-γ. We conducted a study (16) on 13 
Friesian-Zebu crossbred calves, the ages of which lie 
between 6 and 18 months, to investigate the kinetics 
of IFN-γ release in the peripheral blood following 
Bacille Calmette Guerin (BCG) vaccination. After 
being screened for bovine tuberculosis (BTB), the 
calves were vaccinated with 1ml inoculums 
containing 6106 CFU of BCG. The level of IFN-γ in 
the peripheral blood was measured two times before 
vaccination and seven times after vaccination, using a 
sandwich ELISA. The kinetics of IFN-γ post 
vaccination presented itself in three phases: rising, 
falling and steady phases. The concentration of IFN-
γ, before and after vaccination, both in stimulated and 
non-stimulated samples, was statistically significant 
(P<0.01). Strong positive correlation (r=0.86) was 
recorded between the levels of IFN-γ release in avian 
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PPD- and bovine PPD-stimulated samples. Of the 
total 13 calves, 11 (84.6%) reacted positively to 
tuberculin inoculation 15 weeks post vaccination. We 
concluded that the IFN-γ rises immediately after BCG 
vaccination, reaching its peak two weeks post 
vaccination, and then declines gradually in the 
following weeks. The strong positive reaction of 
calves to tuberculin inoculation 15 weeks post 
vaccination showed the capability of BCG in causing 
the release of IFN-γ in the peripheral blood, indicating 
its role in protection against infection with M.  bovis 
in calves. 
 
4. Cross-sectional studies of bovine tuberculosis in 
selected dairy farms and smallholder farms in 
Ethiopia 
 
Zoonotic tuberculosis is prevalent in animals of many 
developing countries where surveillance and control 
activities are often inadequate or unavailable; 
Ethiopia is one of these countries where many 
epidemiologic and public health aspects of the 
infection remain largely unknown. We conducted a 
cross-sectional study (17) to generate baseline 
information on the prevalence of bovine TB and 
related risk factors in selected dairy farms in Ethiopia 
using 1171 dairy cattle in 12 randomly selected state-
owned, private or research dairy farms. Comparative 
intra-dermal tuberculin (CIT) test and bacteriologic 
study through milk culturing were employed. An 
overall individual animal prevalence of 46.8% and a 
herd prevalence of 91.7% were recorded. There were 
significant differences in individual prevalence 
between farms and breeds (pure Holstein and their 
crosses with Zebu). It was also found out that herd 
size and management (sanitation levels) affect the 
prevalence of bovine tuberculosis. Particularly, breed 
and management affected the prevalence of bovine 
TB as confounding variables. M. bovis was isolated in 
the milk of 4 cows out of the 13 reactor cows. The 
widespread occurrence of bovine TB in the study 
farms and isolation of M. bovis from the milk of 
reactor cows signified its economic importance and 
potential risk to public health. Generalization and 
improved use of milk pasteurization within all dairy 
sub-sectors is recommended, and this would affect the 
competitiveness of the dairy sector in Ethiopia. 
 
With the rationale that the introduction of exotic and 
crossbred cattle into Ethiopia has created favourable 
condition for the spread of bovine TB, leaving cattle, 
cattle owners, and consumers of raw cattle products at 
risk for infection from M. bovis, we considered the 
Wuchale-Jida district, which is one of the 12 districts 
in the North Shewa Zone (Ethiopia) where dairying is 
commonly practiced using small herd size. The extent 
of bovine TB in the district in both cattle and humans, 
however, was not known. We conducted a cross-
sectional study (10) on 94 households and 763 (575 
crossbred and 188 indigenous) cattle to determine the 
prevalence of bovine TB and assess its public health 
implications in these smallholder farms. Cluster 
sampling, CCT test, a questionnaire, and 
mycobacteriology were used. Based on the CCT test, 
herd prevalence was 42.6% and individual animal 
prevalence was 7.9%. The individual animal 
prevalence was significantly affected by herd size, 
age and body condition of the animal. Among the 
interviewed households, 24.5% had experienced at 
least one human tuberculosis case in the family. Of 
these families, 43.5% had reactor cattle. Nevertheless, 
no statistically significant association was observed 
between reactor cattle and human tuberculosis cases 
in households. The habit of milk and meat 
consumption was affected by occupation and location 
of household residence. Although the level of 
education influenced the habit of milk consumption, 
it did not impact the habit of meat consumption. Less 
than half (38.3%) of the respondents knew about 
bovine TB, and only 30.8% of the respondents were 
conscious of its transmission from cattle to humans. 
Secondary data analysis from Muka-Turri human 
clinic indicated that 85.6% of the human tuberculosis 
cases were from rural parts of the district. Although 
the bovine TB prevalence seems low, its potential risk 
to public health was important based on food 
consumption, poor sanitary measures, and the lack of 
understanding about its zoonosis. Presently there are 
two projects on bovine TB at ILRI (one on-going and 
one planned): 
 Bovine tuberculosis in the developing world: 
WP5 (the on-going Wellcome Trust funded 
project) 
 Bovine tuberculosis in Ethiopia: molecular 
epidemiology and recombinant vaccine 
development using DNA and attenuated 
poxviruses constructs (a planned PhD 
research proposal for Fufa Dawo) 
 
II. Sleeping Sickness (African Trypanosomosis) and 
Cysticercosis 
ILRI has been working on sleeping sickness (18-25) and 
cysticercosis (26-28), which are among the major 
neglected zoonoses. Building on its long research history 
in trypanosomosis research, ILRI has collaborated with 
local partners, the University of Edinburgh, and FAO in 
understanding better the potential role of veterinary 
interventions to control Sleeping sickness in Uganda. The 
use of mouse model in the design of control of 
trypanosomosis and malaria (29-32) is significant. 
Cysticercosis is a highly complex disease affecting both 
people and pigs. ILRI has been participating in a 
Cysticercosis Working Group of Eastern and Southern 
Africa (CWGESA), which promotes effective 
communication, collaboration and coordination of 
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integrated research and control activities aimed at 
combating cysticercosis.  
 
III. Rift Valley fever (RVF) 
Rift Valley fever (RVF) is an acute viral disease, affecting 
mainly livestock but also humans. The virus is transmitted 
to humans through mosquito bites or by exposure to blood 
and bodily fluids. Drinking raw, unpasteurized milk from 
infected animals can also transmit RVF. Routine 
vaccination of livestock in Africa has been prohibitively 
expensive, leading to endemicity of RVF in most African 
countries. Reports in September 2000 first documented 
RVF occurring outside of Africa in the Kingdom of Saudi 
Arabia and Yemen. Prior to this outbreak, the potential for 
RVF spread into the Arabian Peninsula had already been 
exemplified by a 1977 Egyptian epidemic. This 
appearance of RVF outside the African Continent might 
be related to importation of infected animals from Africa. 
 
IV. Avian influenza or bird flu 
World concern over the devastation the pandemic has 
wrought on the poultry business and the deaths, and risk 
of death, of people whose livelihoods depend on poultry 
in some affected countries is overshadowed by the risk that 
this lethal avian influenza virus will mutate and cross over 
to humans, where it would be transmitted from person to 
person and could cause a human pandemic. The danger is 
real: flu pandemics in the 20th century killed 20 million 
people in 1918, 2 million people in 1957 and 1 million 
people in 1968.  
 
In Africa, national task forces are being assembled in 
countries threatened by the introduction of avian influenza 
through wild bird migrations. South Africa has strong 
technical capacity and recent experience in successfully 
eradicating a type of pathogenic avian influenza not 
caused by H5N1 from its ostrich population. The African 
Union’s Inter-African Bureau of Animal Resources is the 
coordinating body for combating trans-boundary diseases 
in Africa. As the implementing agency of the Pan-African 
Rinderpest Campaign and the Pan-African Control of 
Epizootics program, AU-IBAR has supported national 
programs in epidemio-surveillance and provided technical 
support to national veterinary services.  
 
The Consultative Group on International Agricultural 
Research (CGIAR) and its partners can support 
developing countries in their efforts to prevent and control 
avian influenza in two main ways.  
 
(1) Provide empirical research results and approaches to 
determine the following:  
 The sector-wide impacts of avian influenza and 
the predicted distributional impacts of options for 
its control. Studies by the ILRI and its partners of 
the impacts of disease and disease control options 
on poor people in Asia and Africa provide 
relevant approaches and methodologies. ILRI’s 
operating project on animal health and food 
safety for trade is a partner in a proposal recently 
submitted for such a study in Southeast Asia. The 
International Food Policy Research Institute 
(IFPRI) has investigated the impacts of human 
health issues such as HIV-AIDS on the poor and 
analysed risks to the poor related to food safety 
and biosecurity issues.  
 Alternative institutional and market chain 
arrangements, norms and standards for poultry 
products, the feasibility of implementing 
different control plans, and alternative veterinary 
service delivery options to meet the needs of poor 
poultry producers and consumers. This research 
should be linked to ILRI, IFPRI and FAO’s Pro-
Poor Livestock Policy Initiative (PPLPI) projects 
on livestock markets in Southeast Asia.  
 The benefits and risks of employing alternative 
methods of preventing and controlling avian 
influenza outbreaks for poor people and the 
world at large to guide equitable decision-making 
on the choice of disease control methods and the 
incentives needed to ensure compliance with 
them. The CGIAR has a comparative advantage 
in conducting studies that assess the impacts, 
risks and trade-offs of disease control on different 
groups of poor people.  
 The impacts of avian influenza control options on 
developing countries in terms of their national, 
regional and international markets and trade in 
poultry and poultry products as well as other 
livestock products. This would require research 
by ILRI and IFPRI to integrate field-level 
information to enhance the precision of more 
aggregate macro-economic models, the latter of 
which are already in existence. 
 
(2) Provide immediate support to help strengthen the 
capacity of national and regional organizations in 
developing countries (33), particularly in Africa, in 
epidemio-surveillance, risk assessment, field study design, 
analysis of options for new approaches to veterinary 
service delivery, and decision-support methods and tools. 
This support can be provided to AU-IBAR and national 
task forces by ILRI along with FAO, CIRAD, South 
Africa’s Onderstepoort Veterinary Institute, and others. 
The CGIAR is unlikely to engage in technical research on 
vaccines and diagnostics for avian influenza, given the 
comparative advantage of alternative suppliers world-
wide. The Group has important roles to play nonetheless. 
Beyond making immediate responses to help control 
today’s outbreaks of avian influenza, the CGIAR is well-
positioned to play a strategic role in accelerating the 
capacity of developing countries to understand emerging 
diseases and to design appropriate strategies to deal with 
them effectively. 
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One of the important aspects of the work on livestock 
vaccines involves host functional genomics as it relates to 
livestock diseases that can be transmitted to humans. A 
project investigating resistance to trypanosomosis in cattle 
is shedding light on some of the basic questions of disease 
resistance, which may have implications for human 
medical treatment. ILRI researchers first identified several 
regions of the cattle genome in which genes contributing 
to resistance or susceptibility must lie. They then 
identified genes within a part of the bovine genome that 
affects anaemia, a characteristic of the disease. 
Remarkably, significant differences between cattle breeds 
that are susceptible and resistant to the disease were found 
in one of the candidate genes. Such a result makes it 
possible that the gene in question is responsible for the 
difference in susceptibility to anaemia in the two breeds. 
This is now being further investigated. More recent results 
of this trypanosomosis genomics research appear to have 
implications for medical research on cholesterol.  
 
VI. Livestock, water quality, and human health 
ILRI has recently initiated limited research on water-
mediated impacts on human health and on INRM 
approaches to reducing health risks. Most of this research 
falls within ILRI’s collaboration with the CGIAR 
Challenge Program on Water and Food and the CGIAR 
Comprehensive Assessment of Water Management and 
Agriculture.   Key issues include the transmission of 
water-borne pathogens such as coliform bacteria, 
cryptosporidium, and Fasciola that result from animal 
manure contaminating domestic water supplies and where 
simple remedial interventions are feasible. One recent 
MSc thesis demonstrated, for example, that expansion of 
irrigation into dryland areas may increase the prevalence 
of sheep Fasciolosis. Livestock keeping may also affect 
the ecology of water-dependent disease vectors such as 
mosquitoes.  In collaboration with the CGIAR System 
Wide initiative on Malaria and Agriculture (SIMA), an 
effort is being made to assess the potential for using cattle 
management options that can reduce malaria transmission. 
 
VII. Livestock feed quality and human health 
Aflatoxin in milk – a possible hazard to human health:  
ILRI in collaboration with ICRISAT is investigating 
aflatoxin contamination of fodder (mainly crop residues) 
as a source of aflatoxin content in milk. In selected sites in 
Andhra Pradesh, India, close to 50% of the milk samples 
contained non-permissible levels of aflatoxin. At the same 
time, only one of the collected fodder samples (groundnut 
cake) contained non-permissible levels of alflatoxin. 
Aflatoxin in milk can clearly present a health hazard to the 
consumer. There appears to be a mismatch between non-
permissible levels of aflatoxin in fodder (30μg/kg) and 
milk (0.5μg/kg) which needs further investigation.  
 
VIII. Food safety associated with livestock and 
livestock products 
This research program has focused on identifying the 
public health risks associated with the marketing of 
unpasteurized milk (34-37), with an emphasis on 
developing policies and technologies for improved quality 
and safety without jeopardizing market access for the 
poor. An outcome of this work has been changes in 
government policies towards more acceptance of raw milk 
marketing in several East African countries, based on the 
identified low risks and high dependence of resource poor 
people on these markets.  This work is being expanded, in 
cooperation with IFPRI, to examine the marketing of other 
livestock and livestock products, particularly in South 
Asia. Studies provide policy-relevant analyses of the risks 
and economic benefits to poor farmers, market agents, and 
resource-poor consumers (38). ILRI in collaboration with 
Cornell University (USA) is also analysing the risks faced 
by the poor of contracting zoonotic and food-borne 
diseases and modelling the dynamics of these complex, 
under-reported diseases. 
 
Demand for better quality and safe food is increasing 
among urban consumers, especially among affluent ones. 
This poses threats to the market opportunities of 
smallholder producers who often are unable to access 
technology, inputs and services to produce high quality 
products demanded by the market chains serving high-end 
consumers. ILRI research is trying to understand the 
nature of quality and safety attributes demanded by 
consumers, their willingness to pay for such attributes and 
how smallholders may respond to these through 
participation in market chains. 
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